Back to Search
Start Over
A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With ESB1609, a Selective Agonist to the Sphingosine‐1‐Phosphate Receptor 5
- Source :
- Clinical Pharmacology in Drug Development.
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Pharmaceutical Science
Pharmacology (medical)
Subjects
Details
- ISSN :
- 21607648 and 2160763X
- Database :
- OpenAIRE
- Journal :
- Clinical Pharmacology in Drug Development
- Accession number :
- edsair.doi...........d2df720e85f402bd4d993ab5caeaa059